Bio-Rad Laboratories, Inc. announced Operating income margin guidance remains at about 19% as they manage operating expense plan for the remainder of this year.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
288.4 USD | -0.02% | +0.81% | -10.68% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.68% | 8.23B | |
-6.03% | 180B | |
+1.08% | 109B | |
-2.19% | 68.93B | |
-5.98% | 46.41B | |
+12.31% | 45.43B | |
+7.38% | 43.26B | |
+15.98% | 30.05B | |
+16.10% | 25.19B | |
-6.79% | 23.34B |
- Stock Market
- Equities
- BIO Stock
- News Bio-Rad Laboratories, Inc.
- Bio-Rad Laboratories, Inc. Provides Earnings Guidance for the Year 2022